b Tested in sodium chloride 0.9%.
c Tested in both dextrose 5% and sodium chloride 0.9%.
d Tested in bacteriostatic sodium chloride 0.9% preserved with benzyl alcohol 0.9%.
e Tested in either dextrose 5% or in sodium chloride 0.9%, but the report did not specify which solution.
f Tested in a 1:1 mixture of (1) D5W and D5½S with and without KCl 20 mEq/L, and also (2) D10½S with and without KCl 20 mEq/L.
g Tested in Ringer’s injection, lactated.
h Lyophilized formulation tested.
i Refer to Appendix for the composition of parenteral nutrition solutions. TNA indicates a 3-in-1 admixture, and TPN indicates a 2-in-1 admixture.
j Tested in sterile water for injection.
k Test performed using the formulation WITHOUT edetate disodium.
l Piperacillin component. Piperacillin in an 8:1 fixed-ratio concentration with tazobactam.
m Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.
n Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.
o Test performed using the formulation WITH edetate disodium.
q Imipenem component. Imipenem in a 2:2:1 fixed-ratio concentration with cilastatin and relebactam.
r Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.